ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Matinas Biopharma Holdings Inc

Matinas Biopharma Holdings Inc (MTNB)

3,18
-0,03
(-0,93%)
Fermé 13 Octobre 10:00PM
3,30
0,12
(3,77%)
Après les heures de négociation: 1:59AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
3,18
Prix Achat
-
Prix Vente
-
Volume échangé
12 008
3,10 Fourchette du Jour 3,30
2,95 Plage de 52 semaines 44,50
Cap du marché
Clôture Veille
3,21
Ouverture
3,16
Dernière Transaction
103
@
3.18
Dernière heure de transaction
Volume financier
US$ 37 739
VWAP
3,1428
Volume moyen (3 m)
765 334
Actions en circulation
5 016 323
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,72
Bénéfice par action (BPA)
-4,57
Chiffre d'affairess
1,1M
Bénéfice net
-22,94M

À propos de Matinas Biopharma Holdings Inc

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others. Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Matinas Biopharma Holdings Inc est coté dans le secteur Pharmaceutical Preparations de la American Stock Exchange avec le ticker MTNB. Le dernier cours de clôture d'Matinas Biopharma était de US$3,21. Au cours de la dernière année, les actions de Matinas Biopharma ont été négociées dans une fourchette de prix de US$ 2,95 à US$ 44,50.

Matinas Biopharma compte actuellement 5 016 323 actions en circulation. La capitalisation boursière d'Matinas Biopharma est de US$16,10 million. Matinas Biopharma a un ratio cours/bénéfice (ratio PE) de -0.72.

MTNB Dernières nouvelles

Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update

Signs non-binding term sheet granting global rights to develop and commercialize oral MAT2203 for invasive aspergillosis and potentially other invasive fungal infections 31 patients have enrolled...

Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024

BEDMINSTER, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...

Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program

BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...

Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin

BEDMINSTER, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...

New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024

BEDMINSTER, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.18633.34932.96329303.1818229CS
4-0.49-13.35149863763.674.15992.95379633.36819645CS
12-6.17-65.98930481289.359.352.957653346.38933469CS
26-7.11-69.096209912510.2910.7452.958443257.66275889CS
52-10.325-76.453165494313.50544.52.95306561921.23387344CS
156-49.82-9453632.95144829724.63297369CS
260-31.32-90.782608695734.5124.52.95190833442.48045436CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 61,24
(30,94%)
5,16M
PLAGPlanet Green Holdings Corp
US$ 2,07
(25,50%)
75,47k
WYYWidePoint Corporation
US$ 3,98
(17,54%)
227,28k
SLIStandard Lithium Ltd
US$ 2,40
(14,29%)
5,2M
PWPower REIT
US$ 1,3505
(12,54%)
11,15M
SCHGSchwab US Large Cap Growth
US$ 26,405
(-74,94%)
3,29M
SCHXSchwab US Large Cap
US$ 22,875
(-66,44%)
3,18M
SCHBSchwab US Broad Market
US$ 22,39
(-66,43%)
1,25M
FNDBSchwab Fundamental US Broad Market ETF
US$ 23,591
(-66,36%)
83,78k
FNDXSchwab Fundamental US Large Company ETF
US$ 24,07
(-66,35%)
861,54k
YANGDirexion Daily FTSE China Bear 3X Shares New
US$ 3,187
(-1,64%)
93,9M
FXIiShares China Large Cap
US$ 33,45
(0,69%)
69,11M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 38,67
(2,22%)
58,43M
XLFFinancial Select Sector
US$ 46,51
(1,93%)
51,9M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
US$ 18,96
(-2,27%)
47,86M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock